The wound healing HCC type is very rich in the expression of angiogenic genes, which could be a rationale to use anti-angiogenics in combination with ICI to change the balance between CD8 response and HCC in this type of tumor. This evidence concerns the gene CD8A and hepatocellular carcinoma.